We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Emmanuel J. Ramos
The item has been added to your shopping cart.
Emmanuel J. Ramos
Products
PRODUCTS
Aurolife Pharma, LLC
Jogy George
,
Lata C. Mathew
,
Emmanuel J. Ramos
, and
Unnee Ranjan
Price:
$117.00
View
Aurobindo Pharma Ltd.
Tamil Arasu
,
Jogy George
, and
Emmanuel J. Ramos
Price:
$117.00
View
LTS Lohmann Therapy Systems Corp.
Lata C. Mathew
and
Emmanuel J. Ramos
Price:
$117.00
View
Regi US, Inc.
Emmanuel J. Ramos
Price:
$117.00
View
Regi US, Inc.
Emmanuel J. Ramos
Price:
$117.00
View
Ferring Production, Inc.
Jogy George
,
Emmanuel J. Ramos
, and
Melissa T. Roy
Price:
$117.00
View
Austarpharma LLC
Emmanuel J. Ramos
,
Melissa T. Roy
, and
Youmin Wang
Price:
$117.00
View
Ingenus Pharmaceuticals NJ LLC
Emmanuel J. Ramos
Price:
$117.00
View
Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy
Zakaria I. Ganiyu
,
Neda Hamandi
,
Emmanuel J. Ramos
, and
Nicholas A. Violand
Price:
$117.00
View
Naturex, Inc.
Emmanuel J. Ramos
and
Nancy F. Scheraga
Price:
$117.00
View
View All Products by Emmanuel J. Ramos
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More